Evaluation of naphthoquinones identified the acetylated isolapachol as a potent and selective antiplasmodium agent

References

• Cotter C, Sturrock HJ, Hsiang MS, et al. The changing epidemiology of malaria elimination: new strategies for new challenges. Lancet 2013;382:900–11
   PubMed Web of Science ®Google Scholar
• William T, Rahman HA, Jelip J, et al. Increasing incidence of Plasmodium knowlesi malaria following control of P. falciparum and P. vivax Malaria in Sabah, Malaysia. PLoS Negl Trop Dis 2013;7:e2026
   PubMed Web of Science ®Google Scholar
• Lewis IA, Wacker M, Olszewski KL, et al. Metabolic QTL analysis links chloroquine resistance in Plasmodium falciparum to impaired hemoglobin catabolism. PLoS Genet 2014;10:e1004085
   PubMed Web of Science ®Google Scholar
• Baird JK. Effectiveness of antimalarial drugs. N Engl J Med 2005;352:1565–77
   PubMed Web of Science ®Google Scholar
• Dondorp AM, Nosten F, Yi P, et al. Artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med 2009;361:455–67
   PubMed Web of Science ®Google Scholar
• Carvalho LH, Rocha EM, Raslan DS, et al. U. In vitro activity of natural and synthetic naphthoquinones against erythrocytic stages of Plasmodium falciparum. Braz J Med Biol Res 1988;21:485–7
   PubMed Web of Science ®Google Scholar
• Hudson AT, Randall AW, Fry M, et al. Novel anti-malarial hydroxynaphthoquinones with potent broad spectrum anti-protozoal activity. Parasitology 1985;90:45–55
   PubMed Web of Science ®Google Scholar
• Pinto AV, Ferreira VF, Capella RS, et al. Activity of some naphthoquinones on blood stream forms of Trypanosoma cruzi. Trans Royal Soc Trop Med. Hyg 1987;81:609–10
   PubMed Web of Science ®Google Scholar
• Santhamma KR and Raj RK. Quinone analogues: a drug of choice for the control of filariasis. Biochem Biophys Res Commun 1993;190:201–6
   PubMed Web of Science ®Google Scholar
• Ferguson DJ, Huskinson-Mark J, Araujo FG, Remington JS. An ultrastructural study of the effect of treatment with atovaquone in brains of mice chronically infected with the ME49 strain of Toxoplasma gondii. Int J Exp Pathol 1994;75:111–16
   PubMed Web of Science ®Google Scholar
• Beerahee M. Clinical pharmacology of atovaquone and proguanil hydrochloride. J Travel Med 1999;6:S13–17
   PubMed Web of Science ®Google Scholar
• Baggish AL, Hill DR. Antiparasitic agent atovaquone. Antimicrob Agents Chemother 2002;46:1163–73
   PubMed Web of Science ®Google Scholar
• Nixon GL, Moss DM, Shone AE, et al. Antimalarial pharmacology and therapeutics of atovaquone. J Antimicrob Chemother 2013;68:977–85
   PubMed Web of Science ®Google Scholar
• Pérez-Sacau E, Estévez-Braun A, Ravelo AG, et al. Antiplasmodial activity of naphthoquinones related to lapachol and beta-lapachone. Chem Biodiversity 2005;2:264–74
   PubMed Web of Science ®Google Scholar
• Henry M, Alibert S, Rogier C, et al. Inhibition of efflux of quinolines as new therapeutic strategy in malaria. Curr Top Med Chem 2008;8:563–78
   PubMed Web of Science ®Google Scholar
• Hughes LM, Lanteri CA, O'Neil MT, et al. Design of anti-parasitic and anti-fungal hydroxy-naphthoquinones that are less susceptible to drug resistance. Mol Biochem Parasitol 2011;177:12–19
   PubMed Web of Science ®Google Scholar
• De-Andrade-Neto VF, Goulart MO, da Silva-Filho JF, et al. Antimalarial activity of phenazines from lapachol, beta-lapachone and its derivatives against Plasmodium falciparum in vitro and Plasmodium berghei in vivo. Bioorg Med Chem Lett 2004;14:1145–9
   PubMed Web of Science ®Google Scholar
• Lanfranchi DA, Cesar-Rodo E, Bertrand B, et al. Synthesis and biological evaluation of 1,4-naphthoquinones and quinoline-5,8-diones as antimalarial and schistosomicidal agents. Org Biomol Chem 2012;10:6375–87
   PubMed Web of Science ®Google Scholar
• Hussain H, Specht S, Sarite SR, et al. New quinoline-5,8-dione and hydroxynaphthoquinone derivatives inhibit a chloroquine resistant Plasmodium falciparum strain. Eur J Med Chem 2012;54:936–42
   PubMed Web of Science ®Google Scholar
• Schuck DC, Ferreira SB, Cruz LN, et al. Biological evaluation of hydroxynaphthoquinones as anti-malarials. Malaria J 2013;12:234. doi:10.1186/1475-2875-12-234
   PubMed Web of Science ®Google Scholar
• Sharma A, Santos IO, Gaur P, et al. Addition of thiols to o-quinone methide: new 2-hydroxy-3-phenylsulfanylmethyl [1,4]naphthoquinones and their activity against the human malaria parasite Plasmodium falciparum (3D7). Eur J Med Chem 2013;59:48–53
   PubMed Web of Science ®Google Scholar
• De-Rezende LC, Fumagalli F, Bortolin MS, et al. In vivo antimalarial activity of novel 2-hydroxy-3-anilino-1,4-naphthoquinones obtained by epoxide ring-opening reaction. Bioorg Med Chem Lett 2013;23:4583–6
   PubMed Web of Science ®Google Scholar
• Barbosa-Filho JM, Lima CSA, Amorim ELC, et al. Botanical study, phytochemistry and antimicrobial activity of Tabebuia aurea. Int J Exp Bot 2004;73:221–8
   Google Scholar
• Barbosa TP, Camara CA, Silva TMS, et al. New 1,2,3,4-tetrahydro-1-aza-anthraquinones and 2-aminoalkyl compounds from norlapachol with molluscicidal activity. Bioorg Med Chem 2005;13:6464–9
   PubMed Web of Science ®Google Scholar
• Barbosa-Filho JM, Silva TMS, Giulietti AM, et al. Brazilian patent, PI 0403686-7; 2006, 12 pages. CAN 147:448582
   Google Scholar
• Hernandes MZ, Cavalcanti SM, Moreira DR, et al. Halogen atoms in the modern medicinal chemistry: hints for the drug design. Curr Drug Targets 2010;11:303–14
   PubMed Web of Science ®Google Scholar
• Chalapareddy S, Bhattacharyya MK, Mishra S, Bhattacharyya S. Radicicol confers mid-schizont arrest by inhibiting mitochondrial replication in Plasmodium falciparum. Antimicrob Agents Chemother 2014;58:4341–52
   PubMed Web of Science ®Google Scholar
• Coronado LM, Nadovich CT, Spadafora C. Malarial hemozoin: from target to tool. Biochim Biophys Acta 2014;1840:2032–41
   PubMed Web of Science ®Google Scholar